The effect of magnesium and zinc and probiotic co-supplementation in patients with coronary heart disease and type 2 diabetes mellitus
Not Applicable
- Conditions
- coronary heart disease and type 2 diabetes mellitus.Chronic ischemic heart disease, unspecifiedI25.9
- Registration Number
- IRCT20130211012438N35
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Coronary heart disease patients diagnosed with angiography; Patients with diabetes according to American Diabetes Association criteria; age 40 to 95 years; No smoking
Exclusion Criteria
Thyroid disease; Infection; Consumption of any type of supplement (vitamin, salts, etc.) in the last 3 months; Acute myocardial infarction in the last 3 months; Cardiac surgery in the last 3 months; Significant kidney failure; Significant liver failure; Unwillingness to cooperate; Antibiotic use during study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method